Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ADAP – Adaptimmune Therapeutics plc

Name : Adaptimmune Therapeutics plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.00000000000000
EPSttm :
finviz dynamic chart for ADAP

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.05

EPS Last/This Y

-0.17

EPS This/Next Y

-0.03

Price

0.05

Target Price

Analyst Recom

3.33

Performance Q

-36.7

Relative Volume

Beta

2.39

Ticker: ADAP



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-11-13ADAP0.0549N/AN/A0
2025-11-14ADAP0.0549N/AN/A0
2025-11-17ADAP0.0549N/AN/A0
2025-11-18ADAP0.0549N/AN/A0
2025-11-19ADAP0.0549N/AN/A0
2025-11-20ADAP0.0549N/AN/A0
2025-11-21ADAP0.0549N/AN/A0
2025-11-24ADAP0.0549N/AN/A0
2025-11-25ADAP0.0549N/AN/A0
2025-11-26ADAP0.0549N/AN/A0
2025-12-01ADAP0.0549N/AN/A0
2025-12-02ADAP0.0549N/AN/A0
2025-12-03ADAP0.0549N/AN/A0
2025-12-04ADAP0.0549N/AN/A0
2025-12-05ADAP0.0549N/AN/A0
2025-12-08ADAP0.0549N/AN/A0
2025-12-09ADAP0.0549N/AN/A0
2025-12-10ADAP0.0549N/AN/A0
2025-12-11ADAP0.0549N/AN/A0
2025-12-12ADAP0.0549N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



No data found



2 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-11-13ADAP-98.0400
2025-11-14ADAP-98.0400
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2 items Current Page1 of 1

[stock_market_widget type="chart" template="candlestick" assets="ADAP" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]

Last Quarter Act. EPS​

-0.11

Avg. EPS Est. Current Quarter

-0.12

Avg. EPS Est. Next Quarter

-0.06

Insider Transactions

-98.04

Institutional Transactions

Beta

2.39

Average Sales Estimate Current Quarter

12

Average Sales Estimate Next Quarter

13

Fair Value

Quality Score

69

Growth Score

41

Sentiment Score

9

Actual DrawDown %

99.3

Max Drawdown 5-Year %

-99.4

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.66

Average EPS Est. Cur. Y​

-0.47

EPS Next Y. (Est.)

-0.5

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

214.2

Return on Equity vs Industry %

227.8

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”ADAP” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”ADAP” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Adaptimmune Therapeutics plc
Sector: Healthcare
Industry: Biotechnology
Employees: 506
Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos' decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.
stock quote shares ADAP – Adaptimmune Therapeutics plc Stock Price stock today
news today ADAP – Adaptimmune Therapeutics plc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADAP – Adaptimmune Therapeutics plc yahoo finance google finance
stock history ADAP – Adaptimmune Therapeutics plc invest stock market
stock prices ADAP premarket after hours
ticker ADAP fair value insiders trading